A signed medical certificate – attesting to the severity of the disease – will be required from people over 45 and wishing to be vaccinated against the Covid in the second phase, sources said Wednesday evening.
Earlier today, Union Minister Prakash Javadekar said the second phase of vaccination would begin on March 1, with priority for people over 60 and those over 45 with co-morbidities. He said around 27 crore people will be vaccinated at this point, of which around 10 crore are over 60 years old.
According to sources, the list of what constitutes comorbidity will be finalized and published in two days, but may include chronic diseases of the heart, lungs, kidneys and liver, as well as diabetes, cancer, severe asthma. and mental or learning disabilities. with disabilities.
It can also include people on immunosuppressants, people with morbid obesity, and those who have had an organ, bone marrow or stem cell transplant.
Sources said people in any of these categories should complete a one-page Yes / No form confirming their medical condition and then have the form signed by a GP.
They must then present this form to the vaccination center to be vaccinated.
In private vaccination centers, the price of the vaccine is expected to be capped at around Rs.300, sources said tonight. Mr Javadekar said earlier that shooting would be free at government centers.
The government had previously announced that it would use a mobile app – CoWin (Covid Vaccine Intelligence Network) – to help the public register for their vaccines and locate the nearest vaccination centers.
The application is currently limited to “plant level users” or government employees and users.
Once the app is available to the public, sources said users need to register with their Aadhaar card details, upload photo ID, and then the signed medical certificate.
They can then make a vaccination appointment at a nearby center. People can also show up and be vaccinated, as long as there are doses available and they fall into the eligible categories.
There is no clarity yet on when registrations will open, but sources said the format of the medical certificate will soon be distributed to states. It will also be available in local languages.
India has so far approved two vaccines for emergency use – Covishield (developed by AstraZeneca and the University of Oxford, and manufactured by the Serum Institute) and Bharat Biotech’s Covaxin.
A third – Russia’s Sputnik V – has also requested emergency use and this will be reviewed by an SEC (Subject Matter Expert Committee). Sputnik V has an efficiency rate of 91.6 percent, which is higher than Covishield’s 70 percent. The effectiveness of Covaxin has not yet been confirmed.
There are 1.47 lakh of active Covid cases in India this morning, with 13,742 new cases reported in the past 24 hours. Maharashtra and Kerala are the most affected, with more than 50,000 active cases each.